FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Whitbourn

Research Profile

Devices

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Anatomy

Coronary Vessels

Geographic Areas

Co-author Network

Publications

TOP 3
Giuseppe Ferrante; Patrizia Presbitero; Robert Whitbourn; Peter Barlis
Current applications of optical coherence tomography for coronary intervention.
Michael Haude; Tian Hai Koh; Stephen W L Lee; Akiko Maehara; Alexandre Abizaid; Roberto Botelho; Ecaterina Cristea; Peter den Heijer; Sandra Erbs; Ian Meredith; Helen Parise; Mohd Ali Rosli; Sigmund Silber; Kui-Hian Sim; Pieter R Stella; Huay-Cheem Tan; Sukumaran Thambar; Stefan Verheye; Robert Whitbourn; Stephen G Worthley; Roxana Mehran
The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent.
Takashi Muramatsu; Yoshinobu Onuma; Patrick Washington Serruys; Susan Veldhof; Robert Whitbourn; Alexandre Abizaid; Antonio Bartorelli; Christos V Bourantas; Vasim Farooq; Héctor M García-García; Xiaolin Li; Marie-Angèle Morel
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Whitbourn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Giuseppe Ferrante; Patrizia Presbitero; Robert Whitbourn; Peter Barlis
Current applications of optical coherence tomography for coronary intervention.
International journal of cardiology 2013;165(1):7-16.
2013: Michael Haude; Tian Hai Koh; Stephen W L Lee; Akiko Maehara; Alexandre Abizaid; Roberto Botelho; Ecaterina Cristea; Peter den Heijer; Sandra Erbs; Ian Meredith; Helen Parise; Mohd Ali Rosli; Sigmund Silber; Kui-Hian Sim; Pieter R Stella; Huay-Cheem Tan; Sukumaran Thambar; Stefan Verheye; Robert Whitbourn; Stephen G Worthley; Roxana Mehran
The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent.
JACC. Cardiovascular interventions 2013;6(4):334-43.
2013: Takashi Muramatsu; Yoshinobu Onuma; Patrick Washington Serruys; Susan Veldhof; Robert Whitbourn; Alexandre Abizaid; Antonio Bartorelli; Christos V Bourantas; Vasim Farooq; Héctor M García-García; Xiaolin Li; Marie-Angèle Morel
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.
JACC. Cardiovascular interventions 2013;6(3):247-57.
2013: Andy S Yong; Maulik G Shah; Robert Whitbourn; Andrew Wilson; David Daniels; William F Fearon; Michael Ho; Leonard Kritharides; Jamie Layland; Andrew Macisaac; Martin K Ng
Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis.
JACC. Cardiovascular interventions 2013;6(1):53-8.
2013: Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Chrysafios Girasis; Bill D Gogas; Jung Ho Heo; Jacques Koolen; Xiaolin Li; Dougal R McClean; Ian Meredith; Karine Miquel-Hebert; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Pieter Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Christos V Bourantas; Bernard Chevalier; Bernard De Bruyne; Patrick Washington Serruys
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
Heart (British Cardiac Society) 2013;99(2):98-105.
2012: John A Ormiston; Richard Rapoza; Patrick Washington Serruys; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard de Bruyne; Cecile Dorange; Dariusz Dudek; Karine Miquel Hebert; Jacques Koolen; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; Hector M. Garcia
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Circulation. Cardiovascular interventions 2012;5(5):620-32.
2012: Teruyoshi Kume; Ian Meredith; Stefan Verheye; Katsuhisa Waseda; Robert Whitbourn; Stephen Worthley; Paul G Yock; Alexandre Abizaid; Flavio Roberto Azevedo de Oliveira; Roberto Botelho; Peter J Fitzgerald; Koh Tian Hai; Bon-Kwon Koo; Yasuhiro Honda
Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents.
The Journal of invasive cardiology 2012;24(10):489-93.
2012: Jamie J Layland; Georg Leitl; Andrew I MacIsaac; Jithendra Somaratne; Robert Whitbourn; Andrew T Burns; Andrew Wilson
The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention.
Heart (British Cardiac Society) 2012;98(20):1492-7.
2012: Bo Xu; Robert Whitbourn
Novel anticoagulants for non-valvular atrial fibrillation.
Heart, lung & circulation 2012;21(8):463-7.
2012: Salvatore Brugaletta; Bernard Chevalier; Cecile Dorange; Vasim Farooq; Hector M. Garcia; Josep Gomez-Lara; Jung Ho Heo; Dougal R McClean; Ian Meredith; John A Ormiston; Richard Rapoza; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
The international journal of cardiovascular imaging 2012;28(6):1307-14.
2012: Salvatore Brugaletta; Nico Bruining; Hector M. Garcia; Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; James Oberhauser; John A Ormiston; Maria D Radu; Richard Rapoza; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;8(3):352-8.
2012: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Richard Rapoza; Evelyn Regar; Salvatore Brugaletta; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Leif Thuesen; Susan Veldhof; Robert Whitbourn; Stefan Windecker; Patrick Washington Serruys
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;8(2):214-24.
2012: Bill D Gogas; Jung Ho Heo; Jacques Koolen; Dougal R McClean; Karine Miquel-Hebert; Yoshinobu Onuma; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Maria D Radu; Richard Rapoza; Evelyn Regar; Patrick Washington Serruys; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stefan Windecker; John A Ormiston
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
JACC. Cardiovascular interventions 2012;5(6):656-65.
2012: William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
International journal of cardiology 2012;157(1):96-101.
2012: Vasim Farooq; Hector M Garcìa-Garcìa; Bill D Gogas; Josep Gomez-Lara; Yoshinobu Onuma; Alexandre Abizaid; Antonio Bartorelli; Salvatore Brugaletta; Robert Jan Van geuns; Robert Whitbourn; Patrick Washington Serruys
Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;79(6):880-8.
2012: Juan Luis Gutiérrez-Chico; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Evelyn Regar; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Dariusz Dudek; Frank Gijsen; Leif Thuesen; Jolanda Wentzel; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
JACC. Cardiovascular interventions 2012;5(4):428-35.
2012: Jamie Layland; George Leitl; Andrew I MacIsaac; Jithendra B Somaratne; Robert Whitbourn; Andrew T Burns; Andrew M Wilson
When collateral supply is accounted for epicardial stenosis does not increase microvascular resistance.
Circulation. Cardiovascular interventions 2012;5(1):97-102.
2012: Jamie Layland; Andrew I MacIsaac; Jithendra Somaratne; Robert Whitbourn; Andrew Wilson
Takotsubo cardiomyopathy: reversible elevation in microcirculatory resistance.
Cardiovascular revascularization medicine : including molecular interventions 2012;13(1):66-8.
2011: Ian T Meredith; Mark Webster; Robert Whitbourn; Stephen Worthley; Peter J Fitzgerald; John Ormiston
First-in-human experience with the Medtronic Bifurcation Stent System.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(6):662-9.
2011: Patrick Washington Serruys; Pieter C Smits; Krishnankutty Sudhir; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard De Bruyne; Cecile Dorange; Dariusz Dudek; Hector M. Garcia; Karine Miquel Hebert; Jacques Koolen; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; John A Ormiston
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.
Journal of the American College of Cardiology 2011;58(15):1578-88.
2011: J Layland; I Lim; A M Wilson; Robert Whitbourn
Virtual histology: a window to the heart of atherosclerosis.
Heart, lung & circulation 2011;20(10):615-21.
2011: J Layland; A M Macisaac; Robert Whitbourn; A T Burns; A M Wilson
Integrated coronary physiology in percutaneous intervention: a new paradigm in interventional cardiology.
Heart, lung & circulation 2011;20(10):641-6.
2011: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Yoshinobu Onuma; John A Ormiston; Maria Radu; Richard Rapoza; Evelyn Regar; Salvatore Brugaletta; Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Pieter C Smits; Leif Thuesen; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.
JACC. Cardiovascular interventions 2011;4(9):992-1001.
2011: Roberto Diletti; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Josep Gomez-Lara; Jacques Koolen; Dong Li; Dougal R McClean; Ian Meredith; Yoshinobu Onuma; John A Ormiston; Richard Rapoza; Evelyn Regar; Pieter Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Patrick Washington Serruys
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.
Journal of the American College of Cardiology 2011;58(3):258-64.
2011: Josep Gomez-Lara; Jacques Koolen; Dougal R McClean; Marie-angèle Morel; John A Ormiston; Richard Rapoza; Salvatore Brugaletta; Bernard Chevalier; Bernard De Bruyne; Cecile Dorange; Dariusz Dudek; Vasim Farooq; Hector M. Garcia; Pieter C Smits; Leif Thuesen; Robert Jan Van geuns; Susan Veldhof; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
JACC. Cardiovascular interventions 2011;4(7):789-99.
2011: Yoshinobu Onuma; John A Ormiston; Patrick Washington Serruys; Peter Smits; Leif Thuesen; Robert Whitbourn; Stephan Windecker; Bernard Chevalier; Bernard De Bruyne; Dariusz Dudek; Hector M. Garcia; Josep Gomez; Jacques Koolen; Dougal R McClean; Ian Meredith
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;78(1):3-12.
2011: Salvatore Brugaletta; Bernard Chevalier; Roberto Diletti; Cecile Dorange; Dariusz Dudek; Hector M. Garcia; Scot Garg; Josep Gomez-Lara; Dougal R McClean; Karine Miquel-Hebert; Yoshinobu Onuma; John A Ormiston; Krishnankutty Sudhir; Leif Thuesen; Robert Jan Van geuns; Robert Whitbourn; Stephan Windecker; Patrick Washington Serruys
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
The international journal of cardiovascular imaging 2011;27(6):859-66.
2011: Jamie Layland; Robert Whitbourn; Andrew Wilson; Andrew MacIsaac
Letter by Layland et al regarding article, "Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity".
Circulation. Cardiovascular interventions 2011;4(3):e16; author reply e17.
2011: Katsuhisa Waseda; Robert Whitbourn; Stephen G Worthley; Masao Yamasaki; Yoichiro Hongo; Tomomi Koizumi; Bon-Kwon Koo; Ian T Meredith; John Ormiston; Ryota Sakurai; darren walters; Junya Ako; Peter J Fitzgerald; Yasuhiro Honda
Impact of polymer formulations on neointimal proliferation after zotarolimus-eluting stent with different polymers: insights from the RESOLUTE trial.
Circulation. Cardiovascular interventions 2011;4(3):248-55.
2011: Ian T Meredith; Robert Whitbourn; Douglas Scott; Seif El-Jack; Robaayah Zambahari; Gregg W Stone; Paul S Teirstein; Ruth M Starzyk; Dominic J Allocco; Keith D Dawkins
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(1):84-90.
2011: Salvatore Brugaletta; Hector M. Garcia; Roberto Diletti; Josep Gomez-Lara; Scot Garg; Yoshinobu Onuma; Eun-Seok Shin; Robert Jan Van geuns; Bernard De Bruyne; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Dougal R McClean; Stephan Windecker; Robert Whitbourn; Cecile Dorange; Susan Veldhof; Richard Rapoza; Krishnankutty Sudhir; Nico Bruining; John A Ormiston; Patrick Washington Serruys
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;6(9):1110-6.
2011: Josep Gomez-Lara; Salvatore Brugaletta; Roberto Diletti; Scot Garg; Yoshinobu Onuma; Bill D Gogas; Robert Jan Van geuns; Cecile Dorange; Susan Veldhof; Richard Rapoza; Robert Whitbourn; Stephan Windecker; Hector M. Garcia; Evelyn Regar; Patrick Washington Serruys
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
European heart journal 2011;32(3):294-304.
2011: Andrew J Boyle; Joy Hwang; Alicia Jenkins; Connie Karschimkus; Dharshan Palasubramaniam; Jath Palasubramaniam; Henry Shih; Rich Sievers; Robert Whitbourn; Jianqin Ye; Yerem Yeghiazarians; Daiwei Zheng; Andrew M Wilson
Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.
Journal of translational medicine 2011;9():150.
2010: Patrick Washington Serruys; Yoshinobu Onuma; John A Ormiston; Bernard De Bruyne; Evelyn Regar; Dariusz Dudek; Leif Thuesen; Pieter C Smits; Bernard Chevalier; Dougal McClean; Jacques Koolen; Stephan Windecker; Robert Whitbourn; Ian Meredith; Cecile Dorange; Susan Veldhof; Karine Miquel-Hebert; Richard Rapoza; Hector M García-García
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation 2010;122(22):2301-12.
2010: Josep Gomez-Lara; Hector M. Garcia; Yoshinobu Onuma; Scot Garg; Evelyn Regar; Bernard De Bruyne; Stephan Windecker; Dougal R McClean; Leif Thuesen; Dariusz Dudek; Jacques Koolen; Robert Whitbourn; Pieter C Smits; Bernard Chevalier; Cecile Dorange; Susan Veldhof; Marie-angèle Morel; Ton de Vries; John A Ormiston; Patrick Washington Serruys
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
JACC. Cardiovascular interventions 2010;3(11):1190-8.
2010: Katsuhisa Waseda; Takao Hasegawa; Junya Ako; Yasuhiro Honda; Eberhard Grube; Robert Whitbourn; John Ormiston; Charles O'Shaughnessy; Timothy D Henry; Paul Overlie; Lewis B Schwartz; Krishnankutty Sudhir; Bernard Chevalier; William A Gray; Alan C Yeung; Peter J Fitzgerald
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
Circulation journal : official journal of the Japanese Circulation Society 2010;74(11):2334-9.
2010: Katsuhisa Waseda; Junya Ako; Masao Yamasaki; Tomomi Koizumi; John Ormiston; Stephen G Worthley; Robert Whitbourn; Darren L Walters; Yasuhiro Honda; Ian T Meredith; Peter J Fitzgerald
Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer – results from the RESOLUTE trial –.
Circulation journal : official journal of the Japanese Circulation Society 2010;74(10):2097-102.
2010: Stephen J Duffy; Peter Ruygrok; Craig P Juergens; Horst Sievert; Mark Richards; James Blake; Robert Whitbourn; H Omar Farouque; Terence Pertile; David M Kaye
Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention.
Journal of the American College of Cardiology 2010;56(6):525-6.
2010: Takayuki Okamura; Yoshinobu Onuma; Héctor M García-García; Evelyn Regar; Joanna J Wykrzykowska; Jacques Koolen; Leif Thuesen; Stephan Windecker; Robert Whitbourn; Dougal R McClean; John A Ormiston; Patrick Washington Serruys
3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification.
JACC. Cardiovascular interventions 2010;3(8):836-44.
2010: Dean J Kereiakes; Louis A Cannon; Robert L Feldman; Jeffrey J Popma; Raymond Magorien; Robert Whitbourn; Ira M Dauber; Abram C Rabinowitz; Michael W Ball; Barry Bertolet; Ameer Kabour; Michael C Foster; John C Wang; Paul Underwood; Keith D Dawkins
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial.
Journal of the American College of Cardiology 2010;56(4):264-71.
2010: Ian T Meredith; Stephen G Worthley; Robert Whitbourn; darren walters; Dougal McClean; John A Ormiston; Mark Horrigan; Gerard T Wilkins; Randall Hendriks; Philip Matsis; David Muller; Donald E Cutlip
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;5(6):692-7.
2009: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Donald E Cutlip
Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(7):989-95.
2009: Markus P Schlaich; Paul A Sobotka; Henry Krum; Robert Whitbourn; Anthony Walton; Murray D Esler
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.
Hypertension 2009;54(6):1195-201.
2009: Ian T Meredith; Stephen G Worthley; Robert Whitbourn; darren walters; Dougal McClean; Mark Horrigan; Jeffrey J Popma; Donald E Cutlip; Ann DePaoli; Manuela Negoita; Peter J Fitzgerald
Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.
JACC. Cardiovascular interventions 2009;2(10):977-85.
2009: C Jellis; A Hunter; Robert Whitbourn; Andrew I MacIsaac
Tako-tsubo cardiomyopathy after observing anaphylaxis.
Internal medicine journal 2009;39(9):630-1.
2009: Sandhir B Prasad; Robert Whitbourn; Yuvaraj Malaiapan; Walid Ahmar; Andrew MacIsaac; Ian T Meredith
Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(3):301-7.
2009: Jamie Layland; Christine Jellis; Robert Whitbourn
Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
Cardiovascular revascularization medicine : including molecular interventions 2009;10(1):55-7.
2008: Bernard Chevalier; Carlo Di Mario; Franz-Josef Neumann; Flavio Ribichini; Philip Urban; Jeffrey J Popma; Peter J Fitzgerald; Donald E Cutlip; David O Williams; John A Ormiston; Eberhard Grube; Robert Whitbourn; Lewis B Schwartz
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
JACC. Cardiovascular interventions 2008;1(5):524-32.
2008: Masao Yamasaki; Junya Ako; Yasuhiro Honda; Ali Hassan; Bon Koo; Alexandre Abizaid; Peter Fitzgerald; Robert Whitbourn
Novel guidewire-based stent delivery system: Examination by intravascular ultrasound.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;72(1):47-51.
2007: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Jeffrey J Popma; Donald E Cutlip; Peter J Fitzgerald
Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.
The American journal of cardiology 2007;100(8B):56M-61M.
2007: Ian T Meredith; Stephen Worthley; Robert Whitbourn; darren walters; Jeff Popma; Don Cutlip; Peter Fitzgerald
The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2007;3(1):50-3.
2006: Peter Mossop; Shalini A Amukotuwa; Robert Whitbourn
Controlled blunt microdissection for percutaneous recanalization of lower limb arterial chronic total occlusions: a single center experience.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;68(2):304-10.
2006: Andrew Boyle; Robert Whitbourn; Stephen Schlicht; Henry Krum; Alfred Kocher; Harshal H Nandurkar; Steven Bergmann; Mark Daniell; Justin O'Day; Donna Skerrett; David Haylock; Richard E Gilbert; Silviu Itescu
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.
International journal of cardiology 2006;109(1):21-7.
2005: Ian T Meredith; John A Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Raoul Bonan; Jeffrey J Popma; Donald E Cutlip; Peter Fitzgerald; Ross Prpic; Richard E Kuntz
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(2):157-64.
2004: Patrick Washington Serruys; John A Ormiston; Georgios Sianos; J Eduardo Sousa; Eberhard Grube; Peter den Heijer; Pim de Feyter; Pawel Buszman; Albert Schömig; Jean Marco; Lech Polonski; Leif Thuesen; Andreas M Zeiher; J H Nicholas Bett; Maarten J Suttorp; Helmut D Glogar; Mark Pitney; Gerard T Wilkins; Robert Whitbourn; Susan Veldhof; Karine Miquel; Rachel Johnson; Leslie Coleman; Renu Virmani
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
Journal of the American College of Cardiology 2004;44(7):1363-7.
2004: Patrick Washington Serruys; Muzaffer Degertekin; Kengo Tanabe; Mary E Russell; Giulio Guagliumi; John Webb; Jaap Hamburger; Wolfgang Rutsch; Christoph Kaiser; Robert Whitbourn; Edoardo Camenzind; Ian T Meredith; François Reeves; Christoph Nienaber; Edouard Benit; Clemens Disco; Joerg Koglin; Antonio Colombo
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.
Circulation 2004;109(5):627-33.
2003: Robert Whitbourn; Rajiv Sethi; Eugene Pomerantsev; Peter J Fitzgerald
High-speed rotational atherectomy and coronary stenting: QCA and QCU analysis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;60(2):167-71.
2003: Peter Mossop; Marion Cincotta; Robert Whitbourn
First case reports of controlled blunt microdissection for percutaneous transluminal angioplasty of chronic total occlusions in peripheral arteries.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;59(2):255-8.
2003: Robert Whitbourn; Marion Cincotta; Peter Mossop; Matthew Selmon
Intraluminal blunt microdissection for angioplasty of coronary chronic total occlusions.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;58(2):194-8.
2003: Kim Connelly; Andrew Boyle; Andrew Wilson; Andrew I MacIsaac; Patricia Fox; Robert Whitbourn
Coronary artery stent thrombosis associated with exercise testing.
Heart, lung & circulation 2003;12(1):66-9.
2002: Simon R Dixon; Robert Whitbourn; Michael W Dae; Eberhard Grube; Warren Sherman; Gary L Schaer; J Stephen Jenkins; Donald S Baim; Raymond J Gibbons; Richard E Kuntz; Jeffrey J Popma; Thanh T Nguyen; William W O'Neill
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction.
Journal of the American College of Cardiology 2002;40(11):1928-34.
2002: Andrew Boyle; Andrew M Wilson; Kim Connelly; Louisa McGuigan; Jenny Wilson; Robert Whitbourn
Improvement in timing and effectiveness of external cardiac compressions with a new non-invasive device: the CPR-Ezy.
Resuscitation 2002;54(1):63-7.